Critical illness-related corticosteroid insufficiency (CIRCI) in paediatric patients: a diagnostic and therapeutic

Letteria Anna Morabito1, Domenico Corica2,3, Giorgia Pepe2,3

  • 1Pediatric Unit, Maternal Infant Department, "Gaetano Martino" University Hospital, Via Consolare Valeria, 98122, Messina, Italy. letteria.morabito@gmail.com.

PubMed

Insights

Critical illness-related corticosteroid insufficiency (CIRCI) is a dangerous HPA axis dysfunction in ICU patients, linked to inflammation and higher mortality. This review clarifies CIRCI diagnosis and treatment in children.

Area of Science:

  • Pediatric critical care medicine
  • Pediatric endocrinology
  • Intensive care unit (ICU) management

Background:

  • Critical illness-related corticosteroid insufficiency (CIRCI) is a life-threatening dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis in ICU patients.
  • CIRCI is associated with increased inflammation, coagulation markers, morbidity, prolonged ICU stays, and mortality.
  • Pathogenesis involves reduced CRH-stimulated ACTH release, glucocorticoid resistance, and altered cortisol metabolism.

Purpose of the Study:

  • To define CIRCI in pediatric patients.
  • To provide guidance on diagnosing and treating CIRCI in children based on current literature.
  • To address the ongoing debate regarding diagnostic criteria and prevalence in pediatric age groups.

Main Methods:

  • Narrative review of current literature.
  • Focus on defining CIRCI in the pediatric population.
  • Synthesis of data to advise on diagnosis and treatment strategies.

Main Results:

  • The definition and management of CIRCI in children remain debated among specialists.
  • Lack of consensus on diagnostic criteria and prevalence in pediatric intensive care.
  • Current literature provides a basis for understanding and managing pediatric CIRCI.

Conclusions:

  • CIRCI presents a significant challenge in pediatric critical care.
  • Standardized diagnostic criteria and treatment protocols for pediatric CIRCI are needed.
  • Further research and consensus among specialists are crucial for optimal patient outcomes.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
127
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163